» Articles » PMID: 36680093

Advances in CRISPR-Cas9 for the Baculovirus Vector System: A Systematic Review

Overview
Journal Viruses
Publisher MDPI
Specialty Microbiology
Date 2023 Jan 21
PMID 36680093
Authors
Affiliations
Soon will be listed here.
Abstract

The baculovirus expression vector systems (BEVS) have been widely used for the recombinant production of proteins in insect cells and with high insert capacity. However, baculovirus does not replicate in mammalian cells; thus, the BacMam system, a heterogenous expression system that can infect certain mammalian cells, was developed. Since then, the BacMam system has enabled transgene expression via mammalian-specific promoters in human cells, and later, the MultiBacMam system enabled multi-protein expression in mammalian cells. In this review, we will cover the continual development of the BEVS in combination with CRPISPR-Cas technologies to drive genome-editing in mammalian cells. Additionally, we highlight the use of CRISPR-Cas in glycoengineering to potentially produce a new class of glycoprotein medicines in insect cells. Moreover, we anticipate CRISPR-Cas9 to play a crucial role in the development of protein expression systems, gene therapy, and advancing genome engineering applications in the future.

Citing Articles

The untapped potential of cell culture in disentangling insect-microbial relationships.

Macpherson C, Daisley B, Mallory E, Allen-Vercoe E Microbiome Res Rep. 2024; 3(2):20.

PMID: 38841412 PMC: 11149091. DOI: 10.20517/mrr.2023.66.

References
1.
Mabashi-Asazuma H, Jarvis D . CRISPR-Cas9 vectors for genome editing and host engineering in the baculovirus-insect cell system. Proc Natl Acad Sci U S A. 2017; 114(34):9068-9073. PMC: 5576809. DOI: 10.1073/pnas.1705836114. View

2.
Saifaldeen M, Al-Ansari D, Ramotar D, Aouida M . CRISPR FokI Dead Cas9 System: Principles and Applications in Genome Engineering. Cells. 2020; 9(11). PMC: 7700487. DOI: 10.3390/cells9112518. View

3.
Yin J, Li G, Ren X, Herrler G . Select what you need: a comparative evaluation of the advantages and limitations of frequently used expression systems for foreign genes. J Biotechnol. 2006; 127(3):335-47. DOI: 10.1016/j.jbiotec.2006.07.012. View

4.
Lachmann R . Herpes simplex virus-based vectors. Int J Exp Pathol. 2004; 85(4):177-90. PMC: 2517519. DOI: 10.1111/j.0959-9673.2004.00383.x. View

5.
Pickar-Oliver A, Gersbach C . The next generation of CRISPR-Cas technologies and applications. Nat Rev Mol Cell Biol. 2019; 20(8):490-507. PMC: 7079207. DOI: 10.1038/s41580-019-0131-5. View